Data gathered: August 2
Alternative Data for Quest Diagnostics
About Quest Diagnostics
Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses.
| Price | $170.85 |
| Target Price | Sign up |
| Volume | 1,350,000 |
| Market Cap | $18.7B |
| Year Range | $148.71 - $181.24 |
| Dividend Yield | 1.84% |
| PE Ratio | 20.05 |
| Analyst Rating | 75% buy |
| Industry | Health Care Services |
In the news
 |
Quest Diagnostics (NYSE:DGX) Raised to Buy at Wall Street ZenAugust 2 - ETF Daily News |
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, MedtronicJuly 30 - GlobeNewswire |
|
North America Autoimmune Disease Diagnostics Market Report 2025-2033 Featuring Bio-Rad, Abbott, Roche, Quest Diagnostics, Thermo Fisher Scientific, BioMerieux, Myriad Genetics, Siemens HealthineersJuly 29 - GlobeNewswire |
|
 |
Quest Diagnostics Incorporated's (NYSE:DGX) Intrinsic Value Is Potentially 79% Above Its Share PriceJuly 28 - Yahoo |
|
Quest Diagnostics Incorporated (NYSE:DGX) Shares Purchased by Kestra Private Wealth Services LLCJuly 28 - ETF Daily News |
|
Why Quest Diagnostics (DGX) is a Top Growth Stock for the Long-TermJuly 27 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 2.65B | 1.79B | 863M | 220M | 488M | 2.210 |
| Q4 '24 | 2.62B | 1.76B | 858M | 222M | 507M | 2.230 |
| Q3 '24 | 2.49B | 1.68B | 811M | 226M | 479M | 2.300 |
| Q2 '24 | 2.4B | 1.62B | 776M | 229M | 478M | 2.350 |
| Q1 '24 | 2.37B | 1.61B | 755M | 194M | 431M | 2.040 |
Insider Transactions View All
| KUPPUSAMY KARTHIK filed to sell 8,450 shares at $170. August 1 '25 |
| KUPPUSAMY KARTHIK filed to sell 10,660 shares at $167.4. August 1 '25 |
| KUPPUSAMY KARTHIK filed to sell 10,660 shares at $167.4. August 1 '25 |
| DELANEY MARK E filed to sell 7,498 shares at $175.3. May 14 '25 |
| Davis J. E. filed to sell 130,471 shares at $169.6. April 4 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gil Cisneros |
Feb 12, 25 | Sell | $1K - $15K |
| Ro Khanna |
Dec 6, 24 | Buy | $1K - $15K |
| Earl Blumenauer Democrat |
May 4, 24 | Sell | $1K - $15K |
Read more about Quest Diagnostics (DGX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, lobbying cost, business outlook & linkedin employees.
What is the Market Cap of Quest Diagnostics?
The Market Cap of Quest Diagnostics is $18.7B.
What is Quest Diagnostics' PE Ratio?
As of today, Quest Diagnostics' PE (Price to Earnings) ratio is 20.05.
What is the current stock price of Quest Diagnostics?
Currently, the price of one share of Quest Diagnostics stock is $170.85.
How can I analyze the DGX stock price chart for investment decisions?
The DGX stock price chart above provides a comprehensive visual representation of Quest Diagnostics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Quest Diagnostics shares. Our platform offers an up-to-date DGX stock price chart, along with technical data analysis and alternative data insights.
Does DGX offer dividends to its shareholders?
Yes, Quest Diagnostics (DGX) offers dividends to its shareholders, with a dividend yield of 1.84%. This dividend yield represents Quest Diagnostics' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Quest Diagnostics in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Quest Diagnostics?
Some of the similar stocks of Quest Diagnostics are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.